Unknown PHASE3 INTERVENTIONAL 2-arm NCT01522430

Study of Catheter Based Renal Denervation Therapy in Hypertension (DEPART)

DENERVATION OF RENAL SYMPATHETIC ACTIVITY AND HYPERTENSION STUDY

Sponsor: Erasme University Hospital

Conditions Ambulatory Blood Pressure Renal Denervation Renal Function Resistant Hypertension

Interventions Renal angiography alone Renal angiography followed by renal sympathetic denervation

Updated 5 times since 2017 Last updated: Jan 27, 2012 Started: Jan 31, 2012 Primary completion: Dec 31, 2014 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01522430, this PHASE3 trial focuses on Ambulatory Blood Pressure and Renal Denervation and remains ongoing. Sponsored by Erasme University Hospital, it has been updated 5 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erasme University Hospital

Data source: Erasme University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium